Capstone Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$15.8M Buy
223,599
+8,643
+4% +$575K 0.44% 43
2017
Q1
$14.6M Buy
214,956
+13,100
+6% +$921K 0.41% 47
2016
Q4
$14.5M Buy
201,856
+7,685
+4% +$571K 0.41% 46
2016
Q3
$15.4M Buy
194,171
+70,492
+57% +$5.73M 0.44% 41
2016
Q2
$10.3M Sell
123,679
-1,189
-1% -$106K 0.31% 66
2016
Q1
$11.5M Sell
124,868
-943
-0.7% -$85K 0.33% 62
2015
Q4
$12.7M Buy
125,811
+9,926
+9% +$1.03M 0.37% 52
2015
Q3
$11.4M Buy
115,885
+5,181
+5% +$575K 0.35% 58
2015
Q2
$13M Buy
110,704
+1,692
+2% +$185K 0.37% 55
2015
Q1
$10.7M Buy
109,012
+1,322
+1% +$134K 0.3% 71
2014
Q4
$10.2M Buy
107,690
+12,010
+13% +$1.24M 0.29% 78
2014
Q3
$10.2M Buy
95,680
+1,010
+1% +$98.9K 0.35% 55
2014
Q2
$7.85M Sell
94,670
-24,566
-21% -$1.91M 0.25% 88
2014
Q1
$8.45M Sell
119,236
-18,950
-14% -$1.49M 0.26% 87
2013
Q4
$10.4M Sell
138,186
-96,518
-41% -$6.72M 0.3% 61
2013
Q3
$14.8M Sell
234,704
-65,109
-22% -$3.89M 0.36% 44
2013
Q2
$15.4M Buy
+299,813
New +$15.6M 0.4% 37

Other funds holding GILD

Capstone Asset Management's GILD Position: Q2 2017 in Review

Capstone Asset Management increased its Gilead Sciences (GILD) stake by 4% in Q2 2017, buying an estimated $575K and bringing the position to 223,599 shares worth $15.8M. The position accounts for 0.44% of the portfolio, ranked #43.

Capstone Asset Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Capstone Asset Management held 223,599 shares of Gilead Sciences worth $15.8M as of Q2 2017.
  • Capstone Asset Management bought 8,643 Gilead Sciences shares in Q2 2017, an estimated $575K.
  • Gilead Sciences made up 0.44% of Capstone Asset Management's portfolio in Q2 2017, its #43 holding.
  • Capstone Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.